Page 28 - மருந்து டெலிவரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The company is recalling 10 mg/mL vials of phenylephrine hydrochloride due to potential lack of sterility assurance in several lots of the product. Sagent Pharmaceuticals has announced the voluntary US-wide recall of three lots of Phenylephrine Hydrochloride Injection, USP (10 mg/mL). Recall of the product (manufactured by Indoco Remedies and distributed by Sagent) was initiated by Sagent after hearing customer complaints about potentially loose crimped vial overseals; a non-integral crimped vial overseal may result in a non-sterile product. According to the US Food and Drug Administration (FDA), intravenous administration of a product intended to be sterile that is not actually sterile could result in serious systemic infections, which could end up being life-threatening. To date, Sagent has not received reports of any adverse events associated with this issue.

Drug administrationSagent pharmaceuticalsPhenylephrine hydrochloride injectionIndoco remediesHydrochloride injectionMarkets amp regulationsDrug deliveryContract manufacturing amp logisticsPatient centricityRegulatory affairsSupply chainசகெண்ட் மருந்துகள்சந்தைகள் ஆம்ப் ஒழுங்குமுறைகள்மருந்து டெலிவரிஒப்பந்த உற்பத்தி ஆம்ப் தளவாடங்கள்ஒழுங்குமுறை வாழ்க்கைத்தொழில்கள்